Main Content
PI-RADS
Standards to improve early diagnosis and treatment of prostate cancer
Current Release
PI-RADS 2019 v2.1 is available on the web.
To expedite the transfer of high-quality MRI from laboratories to patients to help improve early diagnosis of clinically significant prostate cancer and reduce unnecessary biopsies and treatment for benign and subclinical diseases.
Further reading:
- PI-RADS v2.1 Report Template: |
Request Permission for PI-RADS
PI-RADS Archive
PI-RADS v2 Module
Using PI-RADS v2.1 for Prostate MRIEducation Activity
License Information
Reporting and Data Systems (RADS) by the ºÚÁÏÍø are licensed under a . Permissions beyond the scope of this license may be available by using our . Contact us: rads@acr.org
Related Resources
European Urology
Letter to the Editor of European Urology Journal Regarding PI-RADS
Radiology
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway
European Urology
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
JºÚÁÏÍø
ºÚÁÏÍø Stakeholder Prostate Summit